/term/price-to-ffo/FRA:NV3P Nanoviricides (FRA:NV3P) Price-to-Funds-From-Operations
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoviricides Inc (FRA:NV3P) » Definitions » Price-to-Funds-From-Operations

Nanoviricides (FRA:NV3P) Price-to-Funds-From-Operations : (As of Jun. 20, 2024)


View and export this data going back to . Start your Free Trial

What is Nanoviricides Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.

Nanoviricides (FRA:NV3P) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoviricides Inc (FRA:NV3P) » Definitions » Price-to-Funds-From-Operations
Comparable Companies
LABP APM NHWK CUBT MBIO AZTR LEXX PHGE VIRI AMTI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
NNVC:USA
Address
1 Controls Drive, Shelton, CT, USA, 06484
Website
http://www.nanoviricides.com
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.